Cargando…
The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017
BACKGROUND: Abuse of prescription opioids [opioid use disorder (OUD), poisoning, and fatal and non-fatal overdose] is a public health and economic challenge that is associated with considerable morbidity and mortality in the USA and globally. OBJECTIVE: To systematically review and summarize the hea...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132448/ https://www.ncbi.nlm.nih.gov/pubmed/30027533 http://dx.doi.org/10.1007/s40258-018-0402-x |
_version_ | 1783354324473085952 |
---|---|
author | Reinhart, Marcia Scarpati, Lauren M. Kirson, Noam Y. Patton, Cody Shak, Nina Erensen, Jennifer G. |
author_facet | Reinhart, Marcia Scarpati, Lauren M. Kirson, Noam Y. Patton, Cody Shak, Nina Erensen, Jennifer G. |
author_sort | Reinhart, Marcia |
collection | PubMed |
description | BACKGROUND: Abuse of prescription opioids [opioid use disorder (OUD), poisoning, and fatal and non-fatal overdose] is a public health and economic challenge that is associated with considerable morbidity and mortality in the USA and globally. OBJECTIVE: To systematically review and summarize the health economics literature published over the last 5 years that describes the economic burden of abuse of prescription opioids. METHODS: Findings from searches of databases including MEDLINE, Embase, and Cochrane CENTRAL as well as hand searches of multiple conference abstracts were screened against predefined inclusion criteria to identify studies reporting cost and healthcare resource utilization (HRU) data associated with abuse of prescription opioids. RESULTS: A total of 49 unique studies were identified. Most of the studies examined direct costs and HRU, which were substantially higher for abusers of prescription opioids than non-abuser controls in several matched cohort analyses (US$20,343–US$28,718 vs US$9716–US$14,079 for mean direct combined annual healthcare costs reported in 6 studies). Although only a small number of studies reported indirect costs, these findings suggest a high societal burden related to productivity losses, absenteeism, morbidity, and mortality among those who abuse opioids. Studies of medication-assisted treatment demonstrated that factors such as adherence, dose, formulation (film or tablet), and relapse during treatment, were associated with direct costs and HRU among treated patients. CONCLUSIONS: This systematic literature review shows that abuse of prescription opioids is characterized by substantial direct healthcare costs, medical utilization, and related societal costs. Future research should further investigate the indirect costs of opioid abuse. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40258-018-0402-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-6132448 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-61324482018-09-14 The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017 Reinhart, Marcia Scarpati, Lauren M. Kirson, Noam Y. Patton, Cody Shak, Nina Erensen, Jennifer G. Appl Health Econ Health Policy Systematic Review BACKGROUND: Abuse of prescription opioids [opioid use disorder (OUD), poisoning, and fatal and non-fatal overdose] is a public health and economic challenge that is associated with considerable morbidity and mortality in the USA and globally. OBJECTIVE: To systematically review and summarize the health economics literature published over the last 5 years that describes the economic burden of abuse of prescription opioids. METHODS: Findings from searches of databases including MEDLINE, Embase, and Cochrane CENTRAL as well as hand searches of multiple conference abstracts were screened against predefined inclusion criteria to identify studies reporting cost and healthcare resource utilization (HRU) data associated with abuse of prescription opioids. RESULTS: A total of 49 unique studies were identified. Most of the studies examined direct costs and HRU, which were substantially higher for abusers of prescription opioids than non-abuser controls in several matched cohort analyses (US$20,343–US$28,718 vs US$9716–US$14,079 for mean direct combined annual healthcare costs reported in 6 studies). Although only a small number of studies reported indirect costs, these findings suggest a high societal burden related to productivity losses, absenteeism, morbidity, and mortality among those who abuse opioids. Studies of medication-assisted treatment demonstrated that factors such as adherence, dose, formulation (film or tablet), and relapse during treatment, were associated with direct costs and HRU among treated patients. CONCLUSIONS: This systematic literature review shows that abuse of prescription opioids is characterized by substantial direct healthcare costs, medical utilization, and related societal costs. Future research should further investigate the indirect costs of opioid abuse. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40258-018-0402-x) contains supplementary material, which is available to authorized users. Springer International Publishing 2018-07-20 2018 /pmc/articles/PMC6132448/ /pubmed/30027533 http://dx.doi.org/10.1007/s40258-018-0402-x Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Systematic Review Reinhart, Marcia Scarpati, Lauren M. Kirson, Noam Y. Patton, Cody Shak, Nina Erensen, Jennifer G. The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017 |
title | The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017 |
title_full | The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017 |
title_fullStr | The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017 |
title_full_unstemmed | The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017 |
title_short | The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017 |
title_sort | economic burden of abuse of prescription opioids: a systematic literature review from 2012 to 2017 |
topic | Systematic Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132448/ https://www.ncbi.nlm.nih.gov/pubmed/30027533 http://dx.doi.org/10.1007/s40258-018-0402-x |
work_keys_str_mv | AT reinhartmarcia theeconomicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017 AT scarpatilaurenm theeconomicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017 AT kirsonnoamy theeconomicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017 AT pattoncody theeconomicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017 AT shaknina theeconomicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017 AT erensenjenniferg theeconomicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017 AT reinhartmarcia economicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017 AT scarpatilaurenm economicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017 AT kirsonnoamy economicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017 AT pattoncody economicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017 AT shaknina economicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017 AT erensenjenniferg economicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017 |